BACKGROUND: Hepatitis C virus infects ~3% of the population and it is a risk factor for hepatocarcinogenesis. The epigenetic mechanisms of HCV-induced hepatocyte transformation towards malignancy in this context are unclear. AIMS: The purpose of this study was to evaluate the effect of HCV core proteins of different genotypes on DNA methyltransferases (DNMTs) induction. MATERIALS/ METHODS: We investigated DNMT1, DNMT3b and E-Cadherin (CDH1) mRNA and protein expression levels in an in vitro model of Huh-7 cells expressing the HCV core protein of different genotypes: 1b, 2a, 3a, 4h and 5a. RESULTS: We found that both mRNA and protein expression levels of DNMT1 and 3b were upregulated in genotype 1b HCV core expressing cells as compared to control cells. DNMT3b mRNA levels did not change in genotypes 2a, 3a, 4h and 5a, but were upregulated at the protein level by genotype 1b, 2a, 3a. CDH1 mRNA expression was downregulated only in genotype 1b, whereas its protein expression resulted in downregulation by the HCV core of genotypes 1b, 2a and 3a. Conversely, no significant changes were observed for DNMTs and CDH1 investigated in Huh-7 cells expressing the genotypes 4h and 5a. Furthermore, we present evidence that HCV core 1b protein expression induces DNMTs overexpression through STAT3 protein as demonstrated by NSC74859 treatment. Moreover, SIRT1 inhibition affected DNMT1 and 3b expression only in HCV core protein genotype 1b expressing cells as demonstrated by treatment with its inhibitor sirtinol. CONCLUSIONS: Our findings suggest that HCV core protein could play a role in HCC development at least in part by altering DNMTs expression.
BACKGROUND:Hepatitis C virus infects ~3% of the population and it is a risk factor for hepatocarcinogenesis. The epigenetic mechanisms of HCV-induced hepatocyte transformation towards malignancy in this context are unclear. AIMS: The purpose of this study was to evaluate the effect of HCV core proteins of different genotypes on DNA methyltransferases (DNMTs) induction. MATERIALS/ METHODS: We investigated DNMT1, DNMT3b and E-Cadherin (CDH1) mRNA and protein expression levels in an in vitro model of Huh-7 cells expressing the HCV core protein of different genotypes: 1b, 2a, 3a, 4h and 5a. RESULTS: We found that both mRNA and protein expression levels of DNMT1 and 3b were upregulated in genotype 1b HCV core expressing cells as compared to control cells. DNMT3b mRNA levels did not change in genotypes 2a, 3a, 4h and 5a, but were upregulated at the protein level by genotype 1b, 2a, 3a. CDH1 mRNA expression was downregulated only in genotype 1b, whereas its protein expression resulted in downregulation by the HCV core of genotypes 1b, 2a and 3a. Conversely, no significant changes were observed for DNMTs and CDH1 investigated in Huh-7 cells expressing the genotypes 4h and 5a. Furthermore, we present evidence that HCV core 1b protein expression induces DNMTs overexpression through STAT3 protein as demonstrated by NSC74859 treatment. Moreover, SIRT1 inhibition affected DNMT1 and 3b expression only in HCV core protein genotype 1b expressing cells as demonstrated by treatment with its inhibitor sirtinol. CONCLUSIONS: Our findings suggest that HCV core protein could play a role in HCC development at least in part by altering DNMTs expression.
Authors: Michel Bernier; Rajib K Paul; Alejandro Martin-Montalvo; Morten Scheibye-Knudsen; Shaoming Song; Hua-Jun He; Sean M Armour; Basil P Hubbard; Vilhelm A Bohr; Lili Wang; Yaping Zong; David A Sinclair; Rafael de Cabo Journal: J Biol Chem Date: 2011-04-05 Impact factor: 5.157
Authors: Qian Zhang; Hong Y Wang; Anders Woetmann; Puthiyaveettil N Raghunath; Niels Odum; Mariusz A Wasik Journal: Blood Date: 2006-08-01 Impact factor: 22.113
Authors: Juan Chen; Bin Zhang; Nathalie Wong; Anthony W I Lo; Ka-Fai To; Anthony W H Chan; Margaret H L Ng; Cecilia Y S Ho; Suk-Hang Cheng; Paul B S Lai; Jun Yu; Ho-Keung Ng; Ming-Tat Ling; Ai-Long Huang; Xue-Fei Cai; Ben C B Ko Journal: Cancer Res Date: 2011-04-28 Impact factor: 12.701
Authors: James Turkson; Joon S Kim; Shumin Zhang; Jing Yuan; Mei Huang; Matthew Glenn; Eric Haura; Said Sebti; Andrew D Hamilton; Richard Jove Journal: Mol Cancer Ther Date: 2004-03 Impact factor: 6.261
Authors: Mona M Hassouna; Mary Naguib; Enas M Radwan; Mohamed Abdel-Samiee; Suzanne Estaphan; Eman Abdelsameea Journal: Asian Pac J Cancer Prev Date: 2020-11-01